Domača stranSYK • NYSE
add
Stryker Corp
370,00 $
Po zaprtju:(0,00 %)0,00
370,00 $
Konec trgovanja: 14. okt., 16:04:52 GMT -4 · USD · NYSE · Izjava
Prejšnji trg. dan.
364,92 $
Dnevni razpon
364,27 $ - 372,95 $
Letni razpon
329,16 $ - 406,19 $
Tržna kapitalizacija
141,45 mrd. USD
Povprečni obseg
1,39 mio.
Razm. P/E
48,96
Dividendna donosnost
0,91 %
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 6,02 mrd. | 11,07 % |
Stroški poslovanja | 2,59 mrd. | 11,87 % |
Čisti dohodek | 884,00 mio. | 7,15 % |
Čista dobičkovnost prihodkov | 14,68 | −3,55 % |
Earnings per share | 3,13 | 11,39 % |
EBITDA | 1,62 mrd. | 15,00 % |
Efektivna davčna stopnja | 12,99 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 2,46 mrd. | 25,91 % |
Skupna sredstva | 46,33 mrd. | 18,40 % |
Skupne obveznosti | 25,14 mrd. | 29,80 % |
Celoten lastniški kapital | 21,19 mrd. | — |
Shares outstanding | 382,31 mio. | — |
Razmerje P/B | 6,58 | — |
Donosnost sredstev | 7,16 % | — |
Donosnost kapitala | 8,63 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 884,00 mio. | 7,15 % |
Denar iz dejavnosti | 1,11 mrd. | 75,51 % |
Denar iz naložb | −104,00 mio. | 11,11 % |
Denar iz financiranja | −989,00 mio. | −2,38 % |
Neto sprememba denarnih sredstev | 55,00 mio. | 112,06 % |
Prost denarni tok | 1,02 mrd. | 79,44 % |
Vizitka
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
Generalni direktor
Datum ustanovitve
1941
Sedež organizacije
Spletno mesto
Zaposleni
53.000
